Landry, M L <br/><br/>
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Mar 2000 
 - 688-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.44.3.688-692.2000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--pharmacology<br/>Cells, Cultured<br/>Cytomegalovirus--drug effects<br/>Cytomegalovirus Infections--virology<br/>Fibroblasts--virology<br/>Foscarnet--pharmacology<br/>Ganciclovir--pharmacology<br/>Humans<br/>Laboratories--standards<br/>Microbial Sensitivity Tests--methods<br/>Reproducibility of Results<br/>Viral Plaque Assay--methods